Patient & Visitor InformationContact Us
  • Publications

    1. Kalpalatha Guntupalli, Nathan Dean, Peter E. Morris, Venkata Bandi, Benjamin Margolis, Emanuel Rivers, Mitchell Levy, Robert F. Lodato, Preeti M. Ismail, Amber Reese, john P. Schaumberg, Rajesh Malik, R. Phillip Dellinger, for the TLF LF-0801 Investigator Group.  A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients with Severe Sepsis Crit Care Med 2013; 41:706-716.

    2. Brian Casserly MD, Richard Read MD, Mitchell M Levy MD. Hemodynamic Monitoring in Sepsis. Critical Care Nursing Clinics of North America (Guest Editor: R. Phillip Dellinger MD MSc; Consulting Editor: Janet Foster PhD RN CNS) WB Saunders Company, 23(1):149-169, March 2011.

    3. Andrew T Levinson MD MPH, Brian P Casserly MD, and Mitchell M Levy MDReducing Mortality in Severe Sepsis and Septic ShockSemin Respir Crit Care Med 2011;32:195-205.

    4. Levy MM, Dellinger P, Townsend S, Linde-Zwirble W, Marshall J, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC, on behalf of the Surviving Sepsis Campaign.  The Surviving Sepsis Campaign:  results of an international guideline-based performance improvement program targeting severe sepsis.  Co-publishedIntensive Care Med 2010 Feb;36(2):222-231, and Crit Care Med 2010 Feb;38(2):367-374.